The company also reported a $1.2 million loss for the period. Cash and cash equivalents were reported as $2.7 million, a significant decrease from the same period last year when the company reported $9.2 million in cash and cash equivalents.
In the first quarter, the company sold three Renaissance Systems for minimally invasive and complex spinal surgery. Operating expenses increased during the first quarter of 2012 due to higher sales and marketing costs. The company continues to penetrate new markets in Asia and Europe in addition to expanding its U.S. sales force.
More Articles on Spine Devices:
Orthopaedic Implant Company Launches Pedicle Screw System
14 Spine Devices Receive FDA 510(k) Clearance in April
TranS1 Q1 Revenue Plummets
https://www.beckersorthopedicandspine.com/orthopedic-a-spine-device-a-implant-news/item/11886-trans1-q1-revenue-plummets-26
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
